Onemednet EBITDA TCAC 5A

Que fait Onemednet ? Onemednet Corp generates revenue through its OneMedNet iRWD solution, which curates regulatory-grade Imaging Real World Data (RWD) for healthcare providers and life science companies. The company de-identifies and indexes clinical image archives using AI/ML technology, including EHR, radiology, cardiology, lab, and path data, enabling providers to unlock internal and third-party research opportunities. It offers both customized data packages and pre-packaged regulatory-grade imaging RWD sets to meet rigorous life science requirements. Life science companies and healthcare providers are the primary buyers of these data solutions, leveraging the federated network of healthcare providers for research and development purposes. The company's technology allows for advanced search and curation of medical imaging data, supported by in-house clinical expertise. By processing data locally at network sites, OneMedNet iRWD ensures compliance with regulatory standards while providing access to a wealth of internal and third-party research opportunities. Healthcare providers utilize the solution to enhance their data utilization, while life science firms purchase the pre-packaged RWD sets for clinical trials and product development. The solution's focus on AI/ML-driven indexing and regulatory-grade curation differentiates it in the healthcare data market. OneMedNet iRWD serves as a bridge between healthcare providers' internal data archives and life science research needs. The company's approach to de-identifying and curating data locally ensures privacy and compliance, which is critical for regulatory-grade data. Buyers include life science companies requiring RWD for drug development and healthcare providers seeking to monetize their imaging data. The solution's ability to integrate with various clinical data types, such as EHR, radiology, and lab systems, broadens its appeal across multiple healthcare segments. Onemednet est l'une des entreprises les plus populaires sur Eulerpool.